English | 繁體

Search in the results

UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
AI-directed formulation strategy design initiates rational drug development Journal article
Wang, Nannan, Dong, Jie, Ouyang, Defang. AI-directed formulation strategy design initiates rational drug development[J]. Journal of Controlled Release, 2025, 378, 619-636.
Authors:  Wang, Nannan;  Dong, Jie;  Ouyang, Defang
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:10.5/10.6 | Submit date：2025/01/22
Formulation Strategy Design  Artificial Intelligence  Rational Drug Development  Poorly Water-soluble Drugs  Positive-unlabeled Learning  Partially Supervised Learning  
Dual-target inhibitors of cholinesterase and GSK-3β to modulate Alzheimer's disease Other
2024-04-01
Authors:  He, Junqiu;  Tam, Kin Yip
Favorite | TC[WOS]:3 TC[Scopus]:4 | Submit date：2024/05/02
Alzheimer's Disease  Cholinesterase  Drug Design Strategy  Dual-target Inhibitors  Gsk-3β  
Dual-target inhibitors of cholinesterase and GSK-3beta to modulate Alzheimer's disease Journal article
He Junqiu, TAM KIN YIP. Dual-target inhibitors of cholinesterase and GSK-3beta to modulate Alzheimer's disease[J]. Drug Discovery Today, 2024, 29(4), 1-8.
Authors:  He Junqiu;  TAM KIN YIP
Adobe PDF | Favorite | TC[WOS]:3 TC[Scopus]:4  IF:6.5/7.3 | Submit date：2024/08/29
Gsk-3b  Cholinesterase  Dual-target Inhibitors  Alzheimer’s Disease  Drug Design Strategy